Introduction
Materials and methods
Comprehensive Pelvic Floor Questionnaire
Study population
Assay methods
Statistical analysis
Results
Parameter | SUI n = 47 | POP n = 46 | p value |
---|---|---|---|
n (%) or mean (± SD) | n (%) or mean (± SD) | ||
Age (years) | 63 (± 11.1) | 65 (± 9.9) | > 0.05 |
Menopause age (years) | 52 (± 2.9) | 52 (± 2.3) | > 0.05 |
Years from menopause | 14 (± 9.6) | 13 (± 9.4) | > 0.05 |
BMI (kg/m2) | 27.3 (± 5.2) | 27.70 (± 5.7) | > 0.05 |
Hypertension | 23 (50%) | 14 (30%) | > 0.05 |
Smoking | 14 (30%) | 10 (22%) | > 0.05 |
Parity | 2.2 (± 1.9) | 2.4 (± 1.7) | > 0.05 |
Mode of delivery | > 0.05 | ||
SVD | 45 (96%) | 42 (91%) | |
Vaginal-operative | 2 (4%) | 3 (7%) | |
Cesarean section | 0 (0%) | 1 (2%) | |
Profession | > 0.05 | ||
Sitting | 16 (34%) | 13 (28%) | |
Physical heavy | 14 (30%) | 19 (42%) | |
Others | 17 (36%) | 14 (30%) |
Domains | SUI = 47 | POP = 46 | p value |
---|---|---|---|
Mean (± SD) | Mean (± SD) | ||
Bladder | 4.32 (± 1.49) | 2.85 (± 1.59) | 0.000* |
Bowel | 2.64 (± 1.29) | 2.64 (± 1.54) | > 0.05 |
Prolapse | 1.09 (± 1.09) | 4.43 (± 2.29) | 0.000 * |
Sexual function | 2.69 (± 1.95) | 2.59 (± 2.03) | > 0.05 |
In all | 2.57 (± 1.09) | 3.24 (± 1.30) | 0.009 * |
Relationship between sex steroid serum levels and quality of life domains in cases with symptomatic POP
Relationship between sex steroid serum levels and quality of life domains in cases with SUI
Parameter | OR | 95% CI | p value |
---|---|---|---|
Age | 0.011 | − 0.067 to 0.089 | 0.870 |
Menopausal age | − 0.001 | − 0.378 to 0.259 | 0.750 |
BMI | − 0.001 | − 0.118 to 0.116 | 0.983 |
Smoking | − 3.3337 | − 4.835 to − 1.839 | 0.000* |
Parity | 0.242 | − 0.160 to 0.645 | 0.046 |
Testosterone | − 8.449 | − 17.480 to 0.582 | 0.066 |
DHEAS | 0.211 | − 0.989 to 1.320 | 0.701 |
Androstendion | 0.194 | − 1.443 to 1.831 | 0.811 |
SHBG | 0.027 | 0.007 to 0.046 | 0.009* |
E2 | − 0.034 | − 0.100 to 0.033 | 0.307 |
POP-Q stage | − 0.079 | − 1.146 to 0.989 | 0.882 |
Multivariate analysis in cases with POP
Parameter | OR | 95% CI | p value |
---|---|---|---|
Age | − 0.158 | − 0.260 to − 0.056 | 0.004* |
Menopausal age | 0.176 | − 0.186 to 0.538 | 0.328 |
BMI | 0.077 | − 0.067 to 0.222 | 0.282 |
Smoking | 1.539 | − 0.130 to 3.208 | 0.069 |
Parity | 0.188 | − 0.258 to 0.634 | 0.396 |
Testosterone | 4.171 | − 6.348 to 14.689 | 0.424 |
DHEAS | − 1.444 | − 2.763 to − 0.126 | 0.033* |
Androstendion | − 0.548 | − 2.361 to 1.285 | 0.551 |
SHBG | − 0.027 | − 0.057 to 0.004 | 0.084 |
E2 | 0.287 | 0.023 to 0.550 | 0.034* |
POP-Q stage | 0.471 | − 0.737 to 1.679 | 0.432 |